20 results on '"Orgiazzi, Jacques"'
Search Results
2. Treatment of adult Graves’ disease
3. Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial
4. Dietary habits during the 2 months following the Chernobyl accident and differentiated thyroid cancer risk in a population-based case–control study
5. Autoimmunité thyroïdienne
6. Thyroid autoimmunity
7. Traitement de la maladie de Basedow : problématiques actuelles
8. Declaración de consenso del Grupo europeo sobre la orbitopatía de Graves (EUGOGO) sobre el tratamiento de la orbitopatía de Graves (OG)
9. Evidence for Transcriptional and Posttranscriptional Alterations of the Sodium/Iodide Symporter Expression in Hypofunctioning Benign and Malignant Thyroid Tumors
10. Cost-effectiveness analysis of gestational diabetes mellitus screening in France
11. Oxidative stress parameters in type I, type II and insulin-treated type 2 diabetes mellitus; insulin treatment efficiency
12. Postmenopause hormone treatment in women with NIDDM or impaired glucose tolerance: the MEDIA randomized clinical trial
13. ANTI–TSH RECEPTOR ANTIBODIES IN CLINICAL PRACTICE
14. The screening for mutations in the thyroglobulin cDNA from six patients with congenital hypothyroidism
15. Purified D-thyroxine in athyreotic patients
16. Evaluation of the fructosamine test in obesity: consequences for the assessment of past glycemic control in diabetes
17. Evidence for several cell populations in human thyroid with distinct glycosphingolipid patterns
18. Characterization of an histone kinase activity specifically found in hyperfunctioning benign thyroid tumors
19. Separation of different protein kinase activities in the human thyroid gland. Evidence for an abnormal form in hyperfunctioning adenomas
20. Management of Graves’ Hyperthyroidism
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.